Literature DB >> 16644760

Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.

Dominique Delbeke1, R Edward Coleman, Milton J Guiberteau, Manuel L Brown, Henry D Royal, Barry A Siegel, David W Townsend, Lincoln L Berland, J Anthony Parker, Karl Hubner, Michael G Stabin, George Zubal, Marc Kachelriess, Valerie Cronin, Scott Holbrook.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16644760

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  184 in total

1.  Medical imaging in new drug clinical development.

Authors:  Yi-Xiang Wang; Min Deng
Journal:  J Thorac Dis       Date:  2010-12       Impact factor: 2.895

2.  The engagement of FDG PET/CT image quality and harmonized quantification: from competitive to complementary.

Authors:  Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01       Impact factor: 9.236

3.  Effectiveness of the addition of the brain region to the FDG-PET/CT imaging area in patients with suspected or diagnosed lung cancer.

Authors:  Bekir Tasdemir; Zuhat Urakci; Zeki Dostbil; Kemal Unal; F Selcuk Simsek; Fatma Teke; Cemil Goya
Journal:  Radiol Med       Date:  2015-11-05       Impact factor: 3.469

4.  3D Auto-Context-Based Locality Adaptive Multi-Modality GANs for PET Synthesis.

Authors:  Yan Wang; Luping Zhou; Biting Yu; Lei Wang; Chen Zu; David S Lalush; Weili Lin; Xi Wu; Jiliu Zhou; Dinggang Shen
Journal:  IEEE Trans Med Imaging       Date:  2018-11-29       Impact factor: 10.048

5.  Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial.

Authors:  Marco Spadafora; Leonardo Pace; Laura Evangelista; Luigi Mansi; Francesco Del Prete; Giorgio Saladini; Paolo Miletto; Stefano Fanti; Silvana Del Vecchio; Luca Guerra; Giovanna Pepe; Giuseppina Peluso; Emanuele Nicolai; Giovanni Storto; Marco Ferdeghini; Alessandro Giordano; Mohsen Farsad; Orazio Schillaci; Cesare Gridelli; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-05       Impact factor: 9.236

6.  Inter-heterogeneity and intra-heterogeneity of αvβ3 in non-small cell lung cancer and small cell lung cancer patients as revealed by 68Ga-RGD2 PET imaging.

Authors:  Fei Kang; Zhe Wang; Guoquan Li; Shengjun Wang; Daliang Liu; Mingru Zhang; Mingxuan Zhao; Weidong Yang; Jing Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-12       Impact factor: 9.236

7.  Recommendations of the Spanish Societies of Radiation Oncology (SEOR), Nuclear Medicine & Molecular Imaging (SEMNiM), and Medical Physics (SEFM) on (18)F-FDG PET-CT for radiotherapy treatment planning.

Authors:  Begoña Caballero Perea; Antonio Cabrera Villegas; José Miguel Delgado Rodríguez; María José García Velloso; Ana María García Vicente; Carlos Huerga Cabrerizo; Rosa Morera López; Luis Alberto Pérez Romasanta; Moisés Sáez Beltrán
Journal:  Rep Pract Oncol Radiother       Date:  2012-11-17

8.  N staging of lung cancer patients with PET/MRI using a three-segment model attenuation correction algorithm: initial experience.

Authors:  A A Kohan; J A Kolthammer; J L Vercher-Conejero; C Rubbert; S Partovi; R Jones; K A Herrmann; P Faulhaber
Journal:  Eur Radiol       Date:  2013-06-14       Impact factor: 5.315

9.  Dynamic changes of FDG uptake and clearance in normal tissues.

Authors:  Gang Cheng; Abass Alavi; Esther Lim; Thomas J Werner; Catherine V Del Bello; Scott R Akers
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

10.  Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B.

Authors:  Klaus Strobel; Reinhard Dummer; Hans C Steinert; Katrin Baumann Conzett; Karin Schad; Marisol Pérez Lago; Jan D Soyka; P Veit-Haibach; Burkhardt Seifert; V Kalff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-06       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.